Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches

Author(s): C. Cervino, R. Pasquali and U. Pagotto

Volume 7, Issue 1, 2007

Page: [21 - 30] Pages: 10

DOI: 10.2174/138955707779317812

Price: $65

Abstract

Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.

Keywords: Endocannabinoid, cannabinoid type 1 receptor, cannabinoid type 1 receptor antagonist, rimonabant, metabolic syndrome


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy